What Researchers Did
This retrospective cohort study investigated the association between statin exposure and osteoradionecrosis of the jaw (ORN) disease resolution in patients diagnosed between 2008 and 2020.
What They Found
The study aimed to measure the association between statin exposure and ORN disease resolution, defining good prognosis as full recovery or improvement. Patients diagnosed between January 2008 and December 2020 were included, with those followed for less than 6 months excluded.
What This Means for Canadian Patients
If statins are found to be effective, Canadian patients with osteoradionecrosis of the jaw could potentially benefit from this treatment to improve disease resolution. This could offer a new therapeutic option for a challenging late complication of radiation therapy.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a retrospective cohort study, it is subject to inherent limitations such as potential confounding factors and reliance on existing medical records.